HK1072935A1 - Condensed camptothecins as antitumor agents - Google Patents

Condensed camptothecins as antitumor agents

Info

Publication number
HK1072935A1
HK1072935A1 HK05104506A HK05104506A HK1072935A1 HK 1072935 A1 HK1072935 A1 HK 1072935A1 HK 05104506 A HK05104506 A HK 05104506A HK 05104506 A HK05104506 A HK 05104506A HK 1072935 A1 HK1072935 A1 HK 1072935A1
Authority
HK
Hong Kong
Prior art keywords
camptothecins
condensed
sup
antitumor agents
identified
Prior art date
Application number
HK05104506A
Other languages
English (en)
Inventor
Murata Takeshi
Niizuma Satoshi
Shimma Nobuo
Suda Hitomi
Tsukazaki Masao
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1072935A1 publication Critical patent/HK1072935A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK05104506A 2001-11-30 2005-05-30 Condensed camptothecins as antitumor agents HK1072935A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01128361 2001-11-30
PCT/EP2002/013216 WO2003045952A2 (en) 2001-11-30 2002-11-25 Condensed camptothecins as antitumor agents

Publications (1)

Publication Number Publication Date
HK1072935A1 true HK1072935A1 (en) 2005-09-16

Family

ID=8179394

Family Applications (2)

Application Number Title Priority Date Filing Date
HK05104506A HK1072935A1 (en) 2001-11-30 2005-05-30 Condensed camptothecins as antitumor agents
HK05109380A HK1077303A1 (en) 2001-11-30 2005-10-21 Hexacyclic compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK05109380A HK1077303A1 (en) 2001-11-30 2005-10-21 Hexacyclic compounds

Country Status (29)

Country Link
US (2) US6825194B2 (de)
EP (1) EP1480984B9 (de)
JP (1) JP4305909B2 (de)
KR (1) KR100895746B1 (de)
CN (1) CN100338066C (de)
AT (1) ATE398131T1 (de)
AU (1) AU2002356720B2 (de)
BR (1) BR0214615A (de)
CA (1) CA2468824C (de)
DE (1) DE60227113D1 (de)
ES (1) ES2307830T3 (de)
GT (1) GT200200250A (de)
HK (2) HK1072935A1 (de)
HU (1) HUP0500062A3 (de)
IL (1) IL162058A0 (de)
MX (1) MXPA04005185A (de)
MY (1) MY136138A (de)
NO (1) NO329005B1 (de)
NZ (1) NZ533568A (de)
PA (1) PA8558901A1 (de)
PE (1) PE20030725A1 (de)
PL (1) PL207510B1 (de)
RS (1) RS51051B (de)
RU (1) RU2299212C2 (de)
TW (1) TWI258481B (de)
UA (1) UA80409C2 (de)
UY (1) UY27560A1 (de)
WO (1) WO2003045952A2 (de)
ZA (1) ZA200404522B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1599484A2 (de) 2003-02-21 2005-11-30 Chugai Seiyaku Kabushiki Kaisha Verfahren zur herstellung von hexacyclischen camptothecin derivaten
BRPI0509732A (pt) 2004-04-09 2007-09-25 Chugai Pharmaceutical Co Ltd pró-fármaco solúvel em água, composição farmacêutica, agente terapêutico, agente antifungo e uso do referido pró-fármaco
TW200744603A (en) * 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
EP1938823A1 (de) * 2005-10-19 2008-07-02 Chugai Seiyaku Kabushiki Kaisha Mittel zur prävention oder behandlung von pankreaskarzinom, ovarialkarzinom oder leberkarzinom mit einem neuen wasserlöslichen prodrug
CN118240003A (zh) 2019-03-29 2024-06-25 免疫医疗有限公司 化合物及其缀合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
HU213136B (en) * 1990-08-14 1997-02-28 Kyorin Seiyaku Kk Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them
JP3008226B2 (ja) * 1991-01-16 2000-02-14 第一製薬株式会社 六環性化合物
JP3359955B2 (ja) * 1992-07-16 2002-12-24 第一製薬株式会社 抗腫瘍剤
GB9402934D0 (en) * 1994-02-16 1994-04-06 Erba Carlo Spa Camptothecin derivatives and process for their preparation
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
PT1017675E (pt) 1997-02-14 2006-09-29 Bionumerik Pharmaceuticals Inc Derivados da camtotecina altamente lipofilos
GB9715821D0 (en) * 1997-07-25 1997-10-01 Pharmacia & Upjohn Spa Amidino-camptothecin derivatives

Also Published As

Publication number Publication date
US7109195B2 (en) 2006-09-19
ZA200404522B (en) 2005-01-04
WO2003045952A3 (en) 2003-10-16
MXPA04005185A (es) 2004-08-11
KR20040062976A (ko) 2004-07-09
EP1480984A2 (de) 2004-12-01
US6825194B2 (en) 2004-11-30
PL207510B1 (pl) 2010-12-31
AU2002356720A1 (en) 2003-06-10
BR0214615A (pt) 2004-09-14
US20030144304A1 (en) 2003-07-31
JP2005511643A (ja) 2005-04-28
EP1480984B9 (de) 2009-03-11
CA2468824A1 (en) 2003-06-05
HK1077303A1 (en) 2006-02-10
NZ533568A (en) 2006-01-27
PL370479A1 (en) 2005-05-30
WO2003045952A2 (en) 2003-06-05
RS47004A (en) 2007-02-05
MY136138A (en) 2008-08-29
TW200408642A (en) 2004-06-01
GT200200250A (es) 2004-01-15
EP1480984B1 (de) 2008-06-11
CA2468824C (en) 2011-01-11
JP4305909B2 (ja) 2009-07-29
RU2004119841A (ru) 2005-03-27
HUP0500062A3 (en) 2012-12-28
UY27560A1 (es) 2003-05-30
RS51051B (sr) 2010-10-31
ES2307830T3 (es) 2008-12-01
RU2299212C2 (ru) 2007-05-20
NO329005B1 (no) 2010-07-19
UA80409C2 (en) 2007-09-25
CN1617874A (zh) 2005-05-18
IL162058A0 (en) 2005-11-20
PE20030725A1 (es) 2003-08-28
AU2002356720B2 (en) 2009-01-29
NO20042729L (no) 2004-08-27
ATE398131T1 (de) 2008-07-15
PA8558901A1 (es) 2003-06-30
KR100895746B1 (ko) 2009-04-30
CN100338066C (zh) 2007-09-19
TWI258481B (en) 2006-07-21
US20050059679A1 (en) 2005-03-17
HUP0500062A2 (hu) 2005-04-28
DE60227113D1 (de) 2008-07-24

Similar Documents

Publication Publication Date Title
ZA200600475B (en) Pyrimidine-2,4-dione derivatives as gonadotripin-releasing hormone receptor antagonists
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
IL172834A0 (en) Pyrimidine-,2,4-dione derivatives and pharmaceutical compositions containing the same
HK1068136A1 (en) Muscarinic antagonists
BG103417A (en) Condensed pyrimidine bicyclic derivatives
HRP20031003A2 (en) 4'-substituted nukleosides
MY138478A (en) Benzazepine derivatives for the treatment of neurological disorders
IL157254A0 (en) N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
BG106003A (en) New n-cyanomethylamides and compositions as protease inhibitors
MXPA06001494A (es) Compuestos de piramidina condensados como inhibidores de canales ionicos gatillados por tension.
PL373414A1 (en) 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands
WO2003022219A3 (en) Biarylamino purine antiproliferative agents
MXPA04006041A (es) Antivirales de piridoquinoxalina.
IL137964A0 (en) Antitumor agents
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
HK1072935A1 (en) Condensed camptothecins as antitumor agents
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
AP2001002306A0 (en) Bridged piperazine derivatives.
IL158806A0 (en) Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
MXPA04005151A (es) Compuestos terapeuticos.
YU46302A (sh) Supstituisani piroli
AP2002002595A0 (en) Heterocyclic amide derivatives.
PL1684763T3 (pl) 6-arylo-7-halogeno-imidazo[1,2-a]pirymidyny jako środki przeciwnowotworowe

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE CHINESE AND ENGLISH TITLE OF INVENTION FROM CONDENSED CAMPTOTHECINS AS ANTITUMOR AGENTS AND TO HEXACYCLIC COMPOUNDS AND

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20121125